Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy-Reference-Cited by-同舟云学术

Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy

Published:2005-10 Issue:4 Volume:95 Page:361-371
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Berger William,Abelson Mark B.,Gomes Paulo J.,Beck Morris,Kimura Stephen,Westbrook Thomas,Storms William,Galant Stanley

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference28 articles.

1. Ocular allergic disease: mechanisms, disease sub-types, treatment;Abelson;Ocul Surface,2003

2. Executive summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis;Dykewicz;Ann Allergy Asthma Immunol,1998

3. Allergic and nonallergic rhinitis;Druce,1998

4. Prevalence of allergic rhinitis in the United States;Nathan;J Allergy Clin Immunol,1997

5. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology;Dykewicz;Ann Allergy Asthma Immunol,1998

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergic Conjunctivitis: Review of Current Types, Treatments, and Trends;Life;2024-05-21

2. Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis;Clinical Ophthalmology;2023-11

3. Prevalence of ocular symptoms in patients suffering from allergic rhinitis in an Indian suburb: A cross-sectional study;IP Journal of Otorhinolaryngology and Allied Science;2023-10-15

4. Diagnosis and pharmacological management of allergic conjunctivitis;Journal of the Korean Medical Association;2023-09-10

5. Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial;Ophthalmology and Therapy;2022-05-18